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Abstract:  
Objectives: To systematically review and meta-analyze the impact of bariatric surgery on 
obese patients with urinary incontinence (UI). 
Methods: A search of Medline, EMBASE, CENTRAL, and PubMed to June 2018 was 
performed using methods pre-published on PROSPERO. Reporting followed the Preferred 
Reporting Items for Systematic Review and Meta-analysis guidelines. Studies comparing UI 
status in obese patients before and after bariatric surgery were included. Primary outcomes 
were the improvement or complete resolution of any UI, stress urinary incontinence (SUI), 
and urgency urinary incontinence (UUI). Secondary outcomes were validated UI 
questionnaire scores. The GRADE approach assessed overall quality of evidence. 
Results: 33 cohort studies (2,910 patients) were included (median follow-up 12 months). 
Bariatric surgery resulted in improvement or resolution of any UI in 56% (95% confidence 
interval [CI] 48–63%), SUI in 47% (95% CI 34–60%), and UUI in 53% (95% CI 32–73%) of 
patients. Moreover, bariatric surgery significantly decreased (P<0.001) questionnaire scores 
such as Urogenital Distress Inventory (UDI) by 13.4 points (95% CI 7.2–19.6), International 
Consultation on Incontinence Questionnaire (ICIQ) by 4.0 points (95% CI 2.3–5.7), and 
Incontinence Impact Questionnaire (IIQ) by 5.3 points (95% CI 3.9-6.6). However, 
worsening or new onset of UI was present in 3% of patients. Quality of evidence was very 
low for all outcomes. 
Conclusion: Half of obese patients report improvement or resolution of UI after bariatric 
surgery, but overall quality of evidence is very low. Comparative studies examining the 
benefits of bariatric surgery in obese patients with UI are warranted. 
 
Keywords: Bariatric surgery, Obesity, Urinary incontinence, Stress urinary incontinence, 
Urge urinary incontinence 
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Introduction 
Urinary incontinence (UI) decreases quality of life, creates emotional distress, and 
imposes economic burden for hundreds of million people worldwide (1). The International 
Continence Society and International Urogynecological Association defines UI as the 
involuntary loss of urine, stress urinary incontinence (SUI) as the involuntary loss of urine on 
effort or physical exertion, or on sneezing or coughing, and urgency urinary incontinence 
(UUI) as the involuntary loss of urine associated with a sudden and compelling desire to pass 
urine (2). From an individual perspective, UUI is the most bothersome symptom in both 
genders, and from societal perspective, SUI is the most burdensome of all urinary symptoms 
in women (3). 
Obesity is a major risk factor for UI. Obesity affects more than one third of adults in 
the United States and is predicted to affect 51.1% by 2030 based on current trends (4). Every 
5-point increase in body mass index (BMI) has been associated with a 30 to 60% increased 
odds of UI over 5 to 10 years (5). Mechanistically, central adiposity in patients with obesity 
may increase intra-abdominal pressure, intravesical pressure, and urethral mobility, causing 
UI (6). All patients with UI may benefit from pelvic floor muscle training, bladder training, 
and weight loss, but traditionally, SUI is treated surgically while UUI can be treated with 
pharmacotherapy including antimuscarinics (7,8). The European Association of Urology 
gives a strong recommendation for obese adults with UI to lose weight and maintain it, 
however, long-term weight loss of at least 10% is only maintained in an estimated 20 to 30% 
of people who undertake lifestyle interventions (9). 
Bariatric surgery is the most effective form of sustained weight loss in patients with 
obesity (10). Earlier studies have also reported a decreased prevalence of UI in obese 
patients, even years after bariatric surgery (11–16). Despite the increasing evidence 
investigating the effect of bariatric surgery on UI, no quantitative synthesis exists. 
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Unfortunately, studies commonly use a wide range of questionnaires and outcome measures 
to evaluate UI, making comparisons difficult, and complicating the assessment of bariatric 
surgery on specific types of UI (12–19).  
UI is not currently a prerequisite for bariatric surgery in patients with clinically severe 
obesity according to the National Institutes of Health consensus statement (20). As UI is 
common among bariatric surgery patients, and as the improvement of obesity-related 
comorbidities is often the motivating factor encouraging patients to pursue bariatric surgery, 
it would be crucial the know its impact on UI (21). We therefore performed a systematic 
review and meta-analysis to establish the effects of bariatric surgery on UI. 
 
Methods  
Search strategy 
      We comprehensively searched the following databases from database inception 
through June 9th, 2018: Medline, EMBASE, Web of Science, Cochrane Central Register of 
Controlled Trials (CENTRAL), and PubMed. The search was designed and conducted by a 
medical research librarian with input from study investigators (complete search strategy 
available in Supplementary Table 1). We searched abstracts published from annual meetings 
of International Urogynecological Association (1999-2014) and International Incontinence 
Society (1999-2014). We did not discriminate full texts by language. This systematic review 
and meta-analysis is conducted and reported in accordance with the Meta-analyses Of 
Observational Studies in Epidemiology (MOOSE) (22). The protocol of this study was 
registered before commencement in the Prospective Register of Systematic Reviews 
(PROSPERO CRD42018106900). 
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Outcomes assessed  
 Primary outcomes included complete resolution or improvement of any UI, SUI, and 
UUI after bariatric surgery. While the exact definition of complete resolution or improvement 
varied between studies, most studies evaluated it using questions from validated 
questionnaires. Secondary outcomes were: (1) Other measures of UI (voids per day, episodes 
of nocturia per week, UI episodes per day, and pad use per day) (2) worsening of UI after 
bariatric surgery (3) adverse events after bariatric surgery. Major complications were 
classified as Clavien-Dindo complication classification grade III or above (conditions 
requiring surgical, radiological, and endoscopic intervention, organ dysfunction, or death) 
(23).  
Study Selection and Data extraction  
Articles were included if they examined the effect of bariatric surgery on any UI, 
including SUI and UUI in patients with class 2 obesity or higher (BMI > 35 kg/m2). Due to 
the heterogeneity present in the definition of UI, we accepted the definition of UI in each 
study as long as it captured the patient’s own perception of incontinence (24). Studies were 
eligible for inclusion if they were cohort studies (prospective or retrospective) and 
randomized controlled trials. Letters, editorials, case-reports, case-series, and review papers 
were excluded.  We included both single-arm studies (effect of bariatric surgery on UI before 
and after surgery without a comparator) or double-arm studies (bariatric surgery versus 
medical therapy or no surgery). We excluded studies with fewer than 10 eligible patients.  
Two reviewers independently evaluated the systematically searched titles and abstract 
using a standardized, pilot-tested form. Discrepancies that occurred at the title and abstract 
screening stages were resolved by automatic inclusion to ensure relevant papers were not 
missed. Discrepancies at the full-text stage were resolved by consensus between two 
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reviewers and if disagreement persisted, a third reviewer was consulted. Two reviewers 
independently conducted data abstraction onto a data collection manual designed a priori. 
Abstracted data included study characteristics (eg. author, year of publication, study design, 
funding source) patient demographics (eg. age, % female, preoperative and postoperative 
BMI, % diabetes, type of bariatric surgery), UI assessment description (eg. validated UI 
questionnaire used, type of survey, type of UI assessed), and outcomes. For studies reporting 
multiple follow-up time points, we analyzed the time point closest to one year. This was 
because previous studies of UI, including the largest observational cohort to date by Subak et 
al., have found that weight loss and the improvement and resolution of UI peak one year after 
bariatric surgery, and decline afterwards (11). In the case of Subak et al., the one year 
prevalence of UI was 18.3% in women and 9.8% in men, while the three year prevalence 
increased to 24.8% in women and 12.2% in men, with the increase attributed to the lack of 
continued follow-up (11).  
Risk of Bias Assessment and Certainty of Evidence 
A post-hoc decision was made to use a UI-specific risk of bias tool for non-
randomized studies that was previously reported in the literature (24). Risk of bias for each 
study was assessed using six criteria, modified from a novel risk of bias tool for UI: sampling 
and representativeness of population, assessment of exposure, assessment of outcome, 
presence of UI at the start of the study, adjustment for confounding, and missing data 
(Supplementary Table 2) (24). Each criterion was rated low or high risk of bias and studies 
with at least two “high risk of bias” criteria were classified as high risk of bias overall. 
Quality of evidence for estimates derived from meta-analyses were assessed by GRADE 
(Grading of Recommendations, Assessment, Development and Evaluation) (25).  
Data Synthesis and Analysis 
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      All statistical analysis and meta-analysis were performed on STATA, version 14 
(StataCorp, College, TX) and Cochrane Review Manager 5.3 (London, United Kingdom). 
Scores for Urogenital Distress Inventory (UDI) and Incontinence Impact Questionnaire (IIQ) 
questionnaires were converted using previously determined formulas to UDI-7 and IIQ-7 
respectively (26). The threshold for statistical significance was set a priori at alpha = 0.05. 
The pooled proportion of patients with improvement or complete resolution of UI after 
bariatric surgery was calculated using the Freeman-Tukey double arcsine transformation of 
proportions. DerSimonian and Laird random effects meta-analysis of proportions was used to 
generate the overall effect size of each outcome. The same method was applied for worsening 
of UI after bariatric surgery. We performed pairwise meta-analyses using a DerSimonian and 
Laird random effects model for continuous variables before and after bariatric surgery. 
Pooled effect estimates were obtained by calculating the mean difference (MD) in outcomes 
along with their respective 95% confidence intervals (CI) to confirm the effect size 
estimation. Assessment of heterogeneity was completed using the inconsistency (I2) statistic. 
We considered I2 higher than 50% to represent considerable heterogeneity (27). For 
significant outcomes, a leave-one-out sensitivity analysis was performed by removing one 
study at a time to confirm that our findings were not driven by any single study. Publication 
bias was assessed using a funnel plot. In addition, we performed subgroup analyses based on 
different types of UI.  
Results 
Study Characteristics  
From 817 potentially relevant reports, 35 studies (all observational; no randomized 
trials) were eligible (12,13,29–38,14,39–48,15,49–52,16–19,21,28). Of these 35, we excluded 
two studies in this systematic review: Shimonov et al. and Leshem et al. (40,48). These 
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studies were excluded because their study cohort were nearly identical, and we suspected 
they included members of the same cohort and decided to avoid double counting of patients. 
Figure 1 represents a detailed PRISMA flow diagram of study selection process. Included 
studies were conducted between 1988 and 2018, with median follow-up of 12 months (range 
6 to 60 months) after bariatric surgery. The weighted mean BMI before surgery was 46.0 ± 
2.8 kg/m2 and 32.2 ± 2.4 kg/m2 at follow-up, with absolute percent reduction of 30%.  
Table 1 presents descriptions of the 33 included studies. Table 2 provides each 
authors’ definition of SUI and UUI, and descriptions of validated questionnaires used to 
assess UI. A wide range of 14 different UI questionnaires were used across included studies 
(complete list of UI questionnaires is available in Supplementary Table 3). Some studies did 
not clarify the method used to assess UI, but still reported UI status before and after surgery 
based on interviewing patients (19,29,33,35,45,52). Bariatric surgeries conducted in the 
included studies were Roux-en-Y gastric bypass (RYGB, 20 studies), Sleeve Gastrectomy 
(SG, 16 studies), Laparoscopic Adjustable Gastric Bypass (LAGB, 11 studies), One 
Anastomosis Gastric Bypass (OAGB, 1 study), Banded Gastric Bypass (BGB, 1 study), 
Vertical Banded Gastroplasty (VBG. 1 study), Biliopancreatic Diversion with Duodenal 
Switch (BPD-DS, 2 study), Horizontal Gastroplasty (1 study), and Jejunoileal Bypass (JIB, 1 
study). 
Effect of bariatric surgery on improvement of UI 
 From the 33 studies included, 30 studies reported any UI (n=2,772), 13 reported SUI 
(n=1,186), and 8 reported UUI (n=720) before and after bariatric surgery. Meta-analysis of 
proportions demonstrated a resolution or improvement of any UI in 56% (95% CI 48–63%) 
of patients, SUI in 47% (95% CI 34–60%), and UUI in 53% (32–73%) of patients after 
bariatric surgery (Figure 2A–C). Complete resolution of any UI was seen in 48% (39–57%), 
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SUI in 39% (24–55%), and UUI in 55% (29–80%) (Supplementary Figure 1A–C). A list of 
outcomes for UI reported in individual studies can be found in Supplementary Table 4A–C. 
Heterogeneity was high across all outcomes ranging from I2 of 87.6 to 96.3%. Subgroup 
analyses based on type of bariatric surgery were not possible because in most studies more 
than one type of bariatric surgeries was conducted but results were not reported separately. 
 
Scores of validated questionnaires after bariatric surgery 
 Similar to the overall improvement and resolution of UI, bariatric surgery resulted in a 
significant decrease in several UI questionnaire scores. The most commonly reported 
questionnaires were UDI, International Consultation on Incontinence Questionnaire (ICIQ), 
IIQ, and Pelvic Organ Prolapse/UI Sexual Questionnaire (PISQ) (Supplementary Table 3). 
Bariatric surgery resulted in a significant decrease in UDI scores by 13.4 points (95% CI 7.2 
to 19.6, P = <.001), ICIQ by 4.0 points (2.3 to 5.7, P = <.001), and IIQ by 5.3 points (3.9 to 
6.6, P = <.001). In contrast, there was no significant difference in PISQ scores (MD -0.3, -2.4 
to 1.8, P = 0.78) (Figure 3A-D). Other UI questionnaires and their scores were sparsely 
reported, or raw scores were not reported and therefore were not meta-analyzed. Sensitivity 
analyses across all outcomes did not affect the pooled estimates or significance of the results. 
 
Narrative summary of other UI outcomes  
Although four measures of UI (voids per day, episodes of nocturia per week, UI 
episodes per day, and pad use per day) were not meta-analyzed due to being reported in a 
small number of studies or due to incomplete data, there appeared to be improvements in all 
four measures. All three studies reporting the number of voids per day before and after 
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bariatric surgery found improvements, with Palleschi et al. reporting that in 120 patients, 
voids decreased from a mean of 9.6 per day before surgery to 6.6 per day following surgery 
(36,44,52). Two studies reporting episodes of nocturia per week both found improvements, 
with Palleschi et al. reporting that episodes of nocturia decreased from 16.1 per week to 7.7 
per week after bariatric surgery (44,52). Both studies reporting pad use per day also found 
improvements with Daucher et al. reporting that pad use decreased from 3.5 per day to 1.75 
per day after bariatric surgery (36,52). All three studies examining incontinence episodes per 
day found improvements with Bump et al. reporting that episodes decreased from 1.91 per 
day to 0.13 per day after bariatric surgery (36,44,52).  
 
Adverse events  
 Worsening or new onset of UI was reported in only 8 (24%) out of 33 studies 
(n=1,302). In total, 2 patients reported worsening of UUI (17), 2 patients reported worsening 
SUI (45), and 54 patients reported worsening or new onset of any UI. Meta-analysis of 
proportions demonstrated that worsening or new onset of UI occurs in 3% (95% 0–14%) 
(Figure 2D). Adverse events related to bariatric surgeries were only reported in 5 (15%) 
studies. In these studies, among 1,007 patients, there were 33 (3%) major complications 
related to bariatric surgery including 3 (0.3%) deaths, 7 (0.7%) band slippages or erosions, 12 
(1%) bowel obstructions, 9 (0.9%) hernias, 3 (0.3%) strictures, and 1 (0.1%) staple line leak 
(Supplementary Table 5).  
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Risk of Bias Assessment and Quality of Evidence  
All studies included in this review drew patients from their chosen database over the 
same time frame, and we judged there to be low risk of bias for sampling and 
representativeness of the population. In 11 studies (31%), it was uncertain how much BMI 
changed after surgery or BMI was not assessed in person. 18 studies (51%) either did not 
report how many patients had UI at the beginning and end of the study or did not explicitly 
exclude confounders. 21 studies (60%) had little missing data with high proportions of 
patients reporting data at baseline and follow-up. 8 studies (23%) adjusted or matched for all 
important confounders including BMI, age, and parity. 22 studies (63%) used self-reported 
validated questionnaires or another method with demonstrated validity (Supplementary Table 
6). The GRADE quality of evidence profile is summarized on Table 3. Because of the high 
loss to follow up and the presence of confounders, the evidence was rated down for serious 
risk of bias for all outcomes. The evidence was rated down for inconsistency in all outcomes 
except IIQ due to high heterogeneity. Due to the low number of participants with outcomes 
reported for PISQ, the evidence was rated down for imprecision. While there was a large 
magnitude of effect for the improvement or complete resolution of any UI, SUI, and UUI, the 
certainty was not upgraded because of major concerns with risk of bias and inconsistency 
(53). Overall, there was a very low certainty of evidence suggesting the effect of estimate is 
uncertain. Symmetry shown in our funnel plot suggests that there is a low possibility of 
publication bias, meaning that there may be a low number of unpublished negative studies 
(Supplementary Figure 2). 
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Discussion  
This is the most comprehensive systematic review and meta-analysis investigating the 
effect of bariatric surgery on UI to date. The current evidence suggests that bariatric surgery 
results in the improvement or resolution of any UI in 56% (95% CI 48–63%), SUI in 47% 
(95% CI 34–60%), and UUI in 53% (95% CI 32–73%) of patients. Complementing the 
objective improvements in UI, this review also demonstrated improvements in quality of life 
and patient-perceived symptoms of UI. Bariatric surgery significantly (P=<.001) decreased 
UDI scores by 13.41 points (95% CI 7.2–19.6), ICIQ score by 4.00 points (95% CI 2.3–5.7), 
and IIQ scores by 5.28 points (95% CI 3.9–6.6) after surgery (very low-quality evidence). 
Conversely, 3% (95% CI 0–14%) of patients experienced worsening or new onset of UI after 
surgery. These data suggest that patients undergoing bariatric surgery may experience 
substantial improvements in UI.  
Previous meta-analyses have been conducted exploring the impact of bariatric surgery 
on UI. Reviews by Lian et al. and Zhang et al. included 11 and 10 cohort studies respectively 
compared to the 33 cohort studies in the present study (54,55). Furthermore, their reviews did 
not separately analyze SUI and UUI, making it uncertain what group of patients with UI 
would benefit from bariatric surgery as the causes of SUI and UUI differ. The present review 
also differs from previous reviews in its rigorous assessment of included studies. While the 
protocol specified that the methodological index for non-randomized studies (MINORS) 
instrument would be used to evaluate of risk of bias on the individual study level, a post-hoc 
decision was made to instead use a modified tool specifically designed for UI that was 
previously reported in the literature.(24) Risk of bias on the body of evidence level was also 
evaluated using GRADE (54,55). The findings of the present review also agree with well-
performed previous studies exploring the effect of both weight loss and bariatric surgery on 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
UI. In a recent large prospective cohort study of bariatric surgery patients with follow-up of 1 
year after surgery, the prevalence of UI decreased from 49 to 18% in women and from 21 to 
10% in men (11).  
The results of this review are encouraging as UI is present in 60 to 70% of obese 
women with a BMI above 40 kg/m2 who are considering bariatric surgery (28,35,56). The 
minimal important differences (MID) for ICIQ-UI is previously reported to be a decrease of 5 
points at 12 months (57). While the MID for UDI-6 and IIQ-7 are not available, the MID for 
their parent questionnaires range from -22.4 to -6.4 points for UDI and -16.5 to -4.6 points for 
UIQ (58). Therefore, the improvements in the ICIQ-UI, UDI-6, and IIQ-7 scores in the 
present review appear to be within the range of error for the MID and may result in important 
improvements in UI for patients. Considering the present review suggests that bariatric 
surgery may improve UI in a significant proportion of obese patients with associated 
improvements in quality of life, morbidly obese patients seeking treatment for UI may benefit 
from discussing possible surgical and non-surgical interventions with both their urologist and 
a bariatric surgeon. While common surgical, pharmacological and behavioral treatments for 
UI target incontinence alone, bariatric surgery has been demonstrated to improve or resolve a 
variety of comorbidities including diabetes, which increases urination, and contributes to the 
development of UI (59). Given the wide range of benefits associated with bariatric surgery, it 
may warrant consideration to treat obese patients with UI and open to bariatric surgery, with 
bariatric surgery first, before determining whether further treatments such as midurethral 
slings for UI are required. Although the overall certainty of evidence is very low for all 
outcomes, obese patients with UI can still reasonably be counseled on the potential benefits 
of weight loss from bariatric surgery. 
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The findings in our study should be interpreted in light of the following limitations. 
First, all studies were observational with no comparators, leading to a very low certainty of 
evidence in all outcomes. No RCTs examining the effect of bariatric surgery on UI were 
found in the literature. Heterogeneity between included studies was high for many outcomes 
including UDI and ICIQ. Although we conducted sensitivity analyses to address this 
heterogeneity, our results failed to explain why heterogeneity was present across pooled 
effect estimates. Moreover, if there were enough studies exclusively reporting one type of 
bariatric surgery and its impact on UI, a subgroup analysis would have been possible to 
reveal the difference in UI outcomes between surgeries (e.g. LSG versus RYGB). Potential 
causes could include the wide range of follow-up time points across included studies, the 
variety of surgeries used, or other comorbidities at an individual patient level. Unfortunately, 
there is no definitive quantitative tool to measure UI, and studies reported a wide range of 
questionnaires, including the Sandvik severity score and Bristol Female Lower Urinary Tract 
Symptoms (BFLUTS) questionnaires which were not reported in enough studies to warrant 
meta-analysis (16,17,60). In many studies, data on the improvement and resolution of UI was 
drawn from validated questionnaires rather than urodynamic assessments. While self-reported 
questionnaire data may be influenced by recall bias, we consider the self-reporting of UI the 
most patient-important outcome. The definition of UI and specific questions asked to 
participants also slightly varied amongst studies, potentially explaining some of the 
heterogeneity in the improvement and resolution of UI, SUI, and UUI. Worsening or new 
onset of UI was also only reported by 8 out of 33 studies, creating the possibility that any 
harms of bariatric surgery on UI were not unreported or even underestimated. 
In conclusion, a very low certainty of evidence exists that bariatric surgery leads to 
improvement or resolution of UI in half of patients, making it a potentially useful strategy for 
management of UI in obese patients. Further large-scale studies with a standardized method 
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of reporting UI outcomes are warranted to confirm the therapeutic benefits of bariatric 
surgery on UI.  
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Figure Legends: 
 
Figure 1. PRISMA Diagram – transparent reporting of systematic reviews and meta-analysis 
flow diagram outlining the search strategy results from initial search to included studies 
 
 Figure 2. Proportion random-effects meta-analysis forest plot of A, improvement or 
complete resolution of any urinary incontinence (UI). B, improvement or complete resolution 
of stress UI. C, improvement or complete resolution of urgency UI. D, worsening or new 
onset of any UI.   
 
Figure 3. Random effects meta-analysis forest plot of A, Urogenital Distress Inventory (UDI) 
scores. B, International Consultation on Incontinence Questionnaire (ICIQ). C, Incontinence 
Impact Questionnaire (IIQ). D, Pelvic Organ Prolapse/UI Sexual Questionnaire (PISQ). 
 
Supplementary Figure 1. Proportion random-effects meta-analysis forest plot of A, 
resolution of any urinary incontinence (UI). B, resolution of stress UI. C, resolution of 
urgency UI.  
 
Supplementary Figure 2. Funnel plot testing the presence of publication bias in studies 
addressing the improvement or resolution of urinary incontinence after bariatric surgery.  
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Study N analyzed Surgery Age % Female Pre-op BMI Post-op BMI % Diabetes Specific inclusion criteria 
Ahroni, 2005 
 
193 LAGB 43.8 ± 10.1 
 
82.8 45.8 ± 7.7 32.3 ± 7 15.4 NIH criteria or patients with significant medical 
co-morbidities that can be improved by weight 
loss. 
Bulbuller, 2017 
 
120 LSG 39.19 ± 9.94 100 46.17 ± 5.35 31.6 ± 4.4 30 Women who met NIH criteria. 
Bump, 1992 
 
13 RYGB 41 ± 11.9 100 49.4 ± 7.9 33.1 ± 6.7 - Women at least 45 kg above their ideal body 
weight as estimated by 1983 Metropolitan Life 
Insurance tables for medium frame. 
Burgio, 2007 
 
92 LRYGB 40.2 (20-55) 100 48.9 ± 7.2 30.2 ± 5.7 15.8 Women with BMI of 40 kg/m2 or more who 
underwent bariatric surgery between October 
2003 and February 2005. 
Castro, 2012 
 
24 Not specified 38.83 ± 7.86 100 46.96 ± 5.77 29.97 ± 3.48 - Women with BMI ≥ 40 kg/m2, and older than 18 
years old. 
Choi, 2010 66 LAGB 40.7 ± 11 89.4 36.1 ± 2.6 - 6.5 18 to 65 years old, BMI of 30–40 kg/m2, 
reported history of 3 years of obesity (BMI > 30 
kg/m2) with failed conservative weight reduction
efforts. 
Cuicchi, 2013 87 RYGB 42 (median) 
(20-66) 
100 43.8 ± 8.5 30 ± 5.9 12 Female patients with BMI of > 30 kg/m2 from 
March 2007 to May 2010. 
Daucher, 2010 34 LRYGB 47 ± 9 100 46 ± 6 33 ± 6 - Women 18 years or older scheduled to undergo 
weight reductive surgery. 
Deitel, 1988 138 JIB, HG, VBG 34.8 ± 8.7 100 - - - Women who were morbidly obese and lost more 
than 50% of their excess weight following 
bariatric surgery. 
Gabriel, 2018 447 LAGB, RYGB, SG 52.5 ± 8 100 - - - Women who were morbidly obese (BMI, > 40 
kg/m2), over the age of 35 years and underwent 
LAGB, RYGB, or SG. 
Kim, 2017 57 LRYGB 38.5 ± 9.5 100 37.5 ± 5.9 28 ± 4.9 - Women from August to December 2012. 
Knepfler, 2016 70 LRYGB, SG, GR 41.4 ± 11.4 100 44.50 ± 6.31 31.83 ± 5.83 18.57 Obese patients between December 2012 and 
January 2014 with BMI > 40kg/m2 or a BMI > 
35kg/m2 with comorbidities. 
Knoepp, 2013 3898 Any bariatric surgery 44.5 ± 0.16 100 - - - Female patient undergoing bariatric surgery 
within the 5-year study period with 
postoperative follow-up period of at least 3 
years. 
Kuruba, 2007 45 LRYGB, LAGB 49 ± 11 97.78 48 ± 7 - 40 Patients who underwent bariatric surgery from 
April 2004 to June 2006 and reported UI. 
Laungani, 2009 58 LRYGB 46 ± 10 100 48 ± 7 - - Morbidly obese females seeking bariatric 
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surgery. 
Leshem, 2018 43 LSG, OAGB 41.6 ± 11.8 100 41.6 ± 4.6 27.5 ± 4.4 17 Female patients (age ≥18 years) with BMI 
between 35-39.9 kg/m2 associated with 
comorbidities, BMI >40 kg/m2, or BMI of 30- 
35 kg/m2 who previously failed bariatric 
surgery, and able to read Hebrew. 
Maher, 2008 324 LRYGB 42.4 ± 11.0 80.5 49.5 ± 9.0 - 29.9 All patients undergoing L-GBP were within the 
guidelines of the 1991 National Institutes of 
Health Con-sensus Conference 
McDermott, 2012 64 LSG, LRYGB 47.5 ± 10.9 100 43.7 ± 6.0 29.0 ± 5.1 30 Female, >18 years of age, fulfill the NIH criteria 
for bariatric surgery (BMI≥ 40 kg/m2 or BMI ≥ 
35 kg/m2 with at least two comorbidities and 
attempted to lose weight in the past) 
O’Boyle, 2015 82 LRYGB, LSG, 
LAGB 
49 ± 9.7 100 50 ± 6.3 34 ± 6.8 - Bariatric surgery was performed in all cases in 
accordance with international guidelines (NICE, 
NIH, IFSO 
Olivera, 2012 36 RYGB, LAGB, LSG 31.28 ± 12.28 100 45.76 ± 6.48 31.55 - Females scheduled to undergo bariatric surgery 
for weight loss who were at least 45 kg above 
ideal body weight (using Metropolitan Life—
Insurance Tables), and/or body mass index 
(BMI) > 35kg/m2with comorbidities, or BMI > 
40kg/m2 without co- morbidities. 
Palleschi, 2015 
 
120 LSG Female: 64.4 ± 
7.77; Male: 
42.4 ± 8.24 
50 Female: 41.2 ± 
2.8; Male: 
40.7 ± 4.9 
Female: 32 ± 
1.8; Male: 31 
± 0.9 
70 Inclusion criteria were morbid obesity (BMI >40
kg/m2), age 18 and 60 y, and eligibility for 
laparoscopic surgery. 
120 Control group Female: 63.6 ± 
3.3; Male: 44 
± 6.34 
50 Female: 40 ± 
2.7; Male: 41 
± 5.5 
Female: 40.2 ± 
3.6; Male: 41.7 
± 4.5 
71 Class 2 obesity (BMI 35–39.9 kg/m2) associated 
with comorbidities, class 3 obesity (BMI >40 
kg/m2) and obese women with BMI 30–35 
kg/m2 who had previously failed bariatric 
surgery. Other criteria for inclusion were age 
over 18 years 
Ranasinghe, 2010 196 LAGB Male: 52.8; 
Female: 47.8 
81.63 Male: 47.3 ± 
12.67; Female: 
43.5 ± 6.65 
Male: 38.4 ± 
6.18; Female: 
35.5 ±6.80 
- Males and females who had underwent LGB 
over a period of 10 years 
Roberson, 2010 193 LAGB, RYGB - 83 50.2 ± 7.7 32.9 ± 7.5 15 Adults who underwent bariatric surgery at 
University of Wisconsin Hospital and Clinics, 
Madison, Wisconsin from July 2002 to May 
2006 
Romero-Talamas, 72 LSG, SG, LAGB 48.8 ± 10.5 100 47.5 ± 9.4 32.7 ± 8.1 - Severely obese women (BMI > 35kg/m2) over 
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2015 age 17 affected by at least 1 type of PFD as 
identified by a positive Pelvic Floor Disorder 
Screening Questionnaire 
Said, 2016 116 LSG, LRYGB 47.6 ± 11.9 72 43.6 ± 6.9 31.6 ± 5.2 31.9 Each patient was discussed during a 
multidisciplinary meeting to choose the 
technique best adapted (LSG or bypass) to the 
patient’s characteristics 
40 Control group - - 43.6 ± 5.9 - - 40 obese patients followed in the nutrition 
department with no surgery scheduled 
Schouten, 2013 60 LRGYB 43; range: 21-
65 
100 43.5; range: 
33.8-60.9 
- 17 Morbidly obese female patients with obesity-
related comorbidities; RGYB patients included 
in the study with no further inclusion or 
exclusion criteria according to the purpose of the
study 
Scozzari, 2013 
 
32 LRYGB, AGB, LSG 39.4 ± 9.5 100 46.3 ± 6.3 31.3 15.6 Inclusion criteria were female gender, standard 
criteria for bariatric surgery, absence of previous 
surgical, obstetrical, or traumatic anal 
sphincterial injuries, absence of previous 
anorectal surgery, absence of chronic diarrhea, 
inflammatory bowel diseases, and neurological 
diseases involving pelvic innervation, and 
informed consent to the study protocol. 
71 Control group 41.3 ± 14 100 21 ± 2.3  0 As control group, 71 age-matched healthy 
volunteer non-obese women selected with the 
same inclusion criteria, except for obesity 
Srinivasa, 2010 171 LSG 44 ± 9 73 50 ± 7 25 ± 7 47.3 Patients greater than 18 years of age were 
selected as per European consensus guidelines 
on surgery for severe obesity (BMI >40kg/m2 or 
>35 kg/m2 with comorbidities). 
Subak, 2015 1987 RYGB, LAGB; SG, 
BPD-DS, BGB 
47; range: 18-
78 
78.8 Female: 45.5; 
range: 41.6-
50.9; Male: 
47.1; range: 
42.6-52.8 
- 31.5 Patients 18 years or older seeking first time 
bariatric surgical procedure with a participating 
surgeon were recruited. Participants had to 
complete the UIQ at baseline and 1 or more 
follow-up assessments within the first 3 
postoperative years. 
Uruc, 2016 22 LSG 34.59 ± 8.07 0 49.57 ± 6.21 38.98 ± 5.51 0 Patients who do not satisfy the exclusion criteria 
as stated 
Vella, 2009 126 Not specified 45.4 ± 10.49 100 47.5 ± 8.12 31 ± 6.47 - All women who underwent bariatric surgery at 
Temple University Hospital between January 
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2004 and March 2006 were identified from the 
Preoperative Information Systems database. 
Wasserberg, 2009 46 RYGB, DS, SG 45; range: 20-
67 
100 45; range: 35-
75 
28; range: 22-
44 
26 Women with BMI of >=35 kg/m2 attending the 
University of Southern California Bariatric 
Surgery Program from December 2003 to 
December 2005. Patients who underwent 
surgery during the study period and achieved a 
>50% excess weight loss postoperatively 
Whitcomb, 2012 69 LAGB, SG 43.3 ± 11.8 100 39.7 ± 6.2 34.4 ± 5.8 - Women with a BMI>=30kg/m2 meeting surgical 
eligibility were screened by telephone or in-
person interview, with eligibility criteria 
including severe or morbid obesity 
(BMI>=40kg/m2) or obesity (BMI>=30kg/m2) 
in the presence of two US NIH-identified 
comorbidities 
Table 1. Characteristics of eligible studies (Pre-op, preoperative; Post-op, post-operative; BMI, Body mass index; LAGB, Laparoscopic adjustable gastric 
binding; LSG, Laparoscopic sleeve gastrectomy; RYGB, Roux-en-y gastric bypass; LRYGB, Laparoscopic roux-en-y gastric bypass; SG, Sleeve 
gastrectomy; JIB, jejunoileal bypass; OAGB, one-anastomosis gastric bypass; -, Not available)  
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Study Validated 
questionnaire used 
Type of survey Type of UI assessed Specific SUI question used Specific UUI question used Response options/ Definition of 
normal-abnormala 
Ahroni, 2005 
 
Not validated, author-
created 
In person Stress -  -  Much better/Somewhat better/No 
change/Somewhat worse/Much 
worse/Don’t know 
Bulbuller, 2017 
 
ICIQ-UI-SF, IIQ-7 Given 
questionnaire 
Stress and urgency When does urine leak? When does urine leak? Never/Leaks before you can get to 
the toilet (UUI)/Leaks when you 
cough or sneeze (SUI)/Leaks when 
you are active or exercising 
(SUI)/All the above (MUI) 
Bump, 1992 
 
Not validated, author-
created 
In person Stress and urgency -  -  No complaints/Complaints of SUI 
(SUI)/Complaints of UUI (UUI)/ 
Complaints of both SUI and UUI 
(MUI) 
Burgio, 2007 
 
UDI-6-SF, IIQ-7,  
MESA 
Given 
questionnaire 
Stress and urgency Does coughing gently or 
hard, sneezing, lifting things, 
bending over, vomiting, 
straining to do something, 
laughing, sexual activity, 
walking briskly, or jogging 
ever cause you to lose urine? 
 
Does finding the toilet is 
occupied or being delayed in 
getting to use it, having the 
feeling that your bladder is 
very full, or having an urge to 
urinate ever cause the loss of 
urine beyond your control? 
Never/Rarely/Sometimes/Often 
Castro, 2012 King’s Health 
Questionnaire-
Portuguese 
In person, given 
questionnaire 
Any urinary 
incontinence 
-  -  No/Yes 
Choi, 2010 Not validated, author-
created 
In person, given 
questionnaire 
Stress -  -  -  
Cuicchi, 2013 PFDI-20, UDI-6-SF, 
PFIQ-7, IIQ-7 
Given 
Questionnaire 
Stress and urgency Do you experience, and if so, 
how much are you bothered 
by leakage related to physical 
activity, coughing, or 
sneezing? 
Do you experience, and if so, 
how much are you bothered 
by leakage related to feeling 
of urgency? 
Not at all/A little 
bit/Moderately/Greatly 
Daucher, 2010 PFDI, UDI, PFIQ, UIQ, 
PISQ-12 
Given 
Questionnaire, 3-
day voiding 
diaries 
Stress and urgency Do you experience, and if so, 
how much are you bothered 
by leakage related to physical 
activity, coughing, or 
sneezing? 
Do you experience, and if
so, how much are you 
bothered by leakage 
related to feeling of 
urgency? 
Not at all/A little 
bit/Moderately/Greatly 
Deitel, 1988 Not validated, author-
created 
In person Stress -  -  -  
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Gabriel, 2018 PFDI-20, UDI-6-SF Mail or online 
questionnaire 
Stress and urgency Do you usually experience 
urine leakage related to 
coughing, sneezing, or 
laughing? 
Do you usually experience 
urine leakage associated with 
a feeling of urgency, that is, a 
strong sensation of needing 
to go to the bathroom? 
Not at all/A little 
bit/Moderately/Greatly 
Kim, 2017 OABSS, PPBC, Sandvik 
ti i
Given 
ti i
Any urinary 
i ti
Do you leak when coughing, 
i l hi lifti
Is leakage accompanied 
ith dd d t
Not at all/Slight/Moderate/Severe 
Knepfler, 2016 PFDI-20, UDI-6 Given 
questionnaire 
Any urinary 
incontinence 
Do you experience, and if so, 
how much are you bothered 
by leakage related to physical 
activity, coughing, or 
sneezing? 
Do you experience, and if so, 
how much are you bothered 
by leakage related to feeling 
of urgency? 
Not at all/A little 
bit/Moderately/Greatly 
Knoepp, 2013 -  Insurance 
database 
Any urinary 
incontinence 
- - None/CPT code for previous UI 
procedures/ICD-9 code for 
UI/Prescription of UI medication. 
Kuruba, 2007 MESA, Sandvik 
questionnaire 
Telephone 
interview, given 
questionnaire 
Stress and urgency Does coughing gently or 
hard, sneezing, lifting things, 
bending over, vomiting, 
straining to do something, 
laughing, sexual activity, 
walking briskly, or jogging 
ever cause you to lose urine? 
 
Does finding the toilet is 
occupied or being delayed in 
getting to use it, having the 
feeling that your bladder is 
very full, or having an urge to 
urinate ever cause the loss of 
urine beyond your control? 
Never/Rarely/Sometimes/Often 
Laungani, 2009 ICIQ-UI-SF Given 
questionnaire 
Stress and urgency When does urine leak? When does urine leak? Never/Leaks before you can get to 
the toilet (UUI)/Leaks when you 
cough or sneeze (SUI)/Leaks when 
you are active or exercising 
(SUI)/All the above (MUI) 
Leshem, 2018  ICIQ-UI-SF, BFLUTS-
SF, PFDI-20, UDI-6, 
PISQ-12 
Given 
questionnaire 
Stress and urgency When does urine leak? When does urine leak? Never/Leaks before you can get to 
the toilet (UUI)/Leaks when you 
cough or sneeze (SUI)/Leaks when 
you are active or exercising 
(SUI)/All the above (MUI) 
Maher, 2008 Not validated, author-
created 
In person Any urinary 
incontinence 
-  -  -  
McDermott, 2012 PFDI-20, PFIQ-7 In person, given 
questionnaire 
Stress and urgency  Do you usually experience 
urine leakage related to 
coughing, sneezing or 
laughing? 
Do you usually experience 
urine leakage associated with 
a feeling of urgency, that is, a 
strong sensation of needing 
to go to the bathroom? 
Not present/not at 
all/somewhat/moderately/quite a bit 
This article is protected by copyright. All rights reserved. 
O’Boyle, 2015 ICIQ-UI-SF In person, given 
questionnaire 
Stress and urgency  When does urine leak? When does urine leak? Never/Leaks before you can get to 
the toilet (UUI)/Leaks when you 
cough or sneeze (SUI)/Leaks when 
you are active or exercising 
(SUI)/All the above (MUI) 
Olivera, 2012 PFIQ/IIQ, PISQ-12 In person, mail, 
telephone 
interview 
Any urinary 
incontinence 
-  -  Yes/No 
Palleschi, 2015 OABq-SF In person, given 
questionnaire 
Urgency  N/A; SUI part of exclusion 
criteria 
During the past 4 weeks, how 
bothered were you by an 
uncomfortable urge to 
urinate? During the past 4 
weeks, how bothered were 
you by a sudden urge to 
urinate with little or no 
warning? 
Not at all, a little bit, somewhat, quite
a bit, a great deal, a very great deal 
Ranasinghe, 2010 ICIQ-SF Mailed Stress and urgency When does urine leak? When does urine leak? Never/Leaks before you can get to 
the toilet (UUI)/Leaks when you 
cough or sneeze (SUI)/Leaks when 
you are active or exercising 
(SUI)/All the above (MUI) 
Roberson, 2010 Not validated; author-
created 
Mailed Stress, urgency, mixed Do you leak urine when you 
perform some physical 
activity such as coughing, 
sneezing, lifting, or exercise? 
Do you leak urine when you 
have the strong feeling that 
you needed to empty your 
bladder but cannot get to the 
toilet fast enough? 
Yes/No 
Romero-Talamas, 2015 PFDI-20, PFIQ-7, PISQ-
12 
In person, given 
questionnaire 
Stress and urgency  Do you usually experience 
urine leakage related to 
coughing, sneezing or 
laughing? 
Do you usually experience 
urine leakage associated with 
a feeling of urgency, that is, a 
strong sensation of needing 
to go to the bathroom? 
Not present/not at 
all/somewhat/moderately/quite a bit 
Said, 2016 ICIQ In person, given 
questionnaire, 
follow up by mail 
Stress and urgency When does urine leak? When does urine leak? Never/Leaks before you can get to 
the toilet (UUI)/Leaks when you 
cough or sneeze (SUI)/Leaks when 
you are active or exercising 
(SUI)/All the above (MUI) 
Schouten, 2013 Not validated; author 
created 
In person, given 
questionnaire 
Any urinary 
incontinence 
-  -  Yes/No 
Scozzari, 2013 PFDI-20, PFIQ-7  In person, given Stress and urgency  Do you usually experience Do you usually experience Not present/not at 
This article is protected by copyright. All rights reserved. 
questionnaire urine leakage related to 
coughing, sneezing or 
laughing? 
urine leakage associated with 
a feeling of urgency, that is, a 
strong sensation of needing 
to go to the bathroom? 
all/somewhat/moderately/quite a bit 
Srinivasa, 2010 Not validated; author 
created 
Retrospective Stress -  -  -  
Subak, 2015 UIQ In person, given 
questionnaire 
Stress In the past 3 months, how 
often have you typically 
leaked urine, even a small 
amount with a physical 
activity like coughing, 
sneezing, lifting, or exercise? 
In the past 3 months, how 
often have you typically felt 
an urge or the feeling that 
you needed to empty your 
bladder, but you could not 
get to the toilet fast enough? 
Never/ less than once per month, 
monthly (once or more each month),
weekly (once or more each week), or
daily (once or more each day). 
Uruc, 2016 ICIQ-SF Given 
questionnaire 
Stress and urgency When does urine leak? When does urine leak? Never/Leaks before you can get to 
the toilet (UUI)/Leaks when you 
cough or sneeze (SUI)/Leaks when 
you are active or exercising 
(SUI)/All the above (MUI) 
Vella, 2009 UDI-6, IIQ-7 Mailed Stress and urgency  Urine leakage related to 
physical activity, coughing, 
or sneezing? 
Urine leakage related to 
physical activity, coughing or 
sneezing? 
Not at all/A little 
bit/Moderately/Greatly 
Wasserberg, 2009 PFIQ, PFDI Given, in person Stress and urgency Do you usually experience 
urine leakage related to 
coughing, sneezing or 
laughing? 
Do you usually experience 
urine leakage associated with 
a feeling of urgency, that is, a 
strong sensation of needing 
to go to the bathroom? 
Not present/not at 
all/somewhat/moderately/quite a bit 
Whitcomb, 2012 PFIQ, PFDI, PISQ Given Stress and urgency Do you usually experience 
urine leakage related to 
coughing, sneezing or 
laughing? 
Do you usually experience 
urine leakage associated with 
a feeling of urgency, that is, a 
strong sensation of needing 
to go to the bathroom? 
Not present/not at 
all/somewhat/moderately/quite a bit 
Table 2. Urinary incontinence assessment in eligible studies (UI, urinary incontinence; ICIQ-UI-SF, International consultation on incontinence questionnaire 
– urinary incontinence - short form; IIQ, Incontinence impact questionnaire; UDI-6-SF, Urogenital distress inventory-6-short form; MESA, Medical, 
Epidemiologic and Social Aspects of Aging Questionnaire; PFDI-20, Pelvic Floor Disability Index-20; PFIQ-7, Pelvic floor impact questionnaire 7; PISQ-12, 
Pelvic organic prolapse/urinary incontinence sexual questionnaire 12; OABSS, Overactive bladder symptom score; PPBC, Patient perception of bladder 
condition; BFLUTS, Bristol Female Lower Urinary Tract Symptoms; UIQ, Urinary Impact Questionnaire; OAB-q, Overactive Bladder Questionnaire; -, not 
reported) 
aCut-off point (threshold) used for normal versus abnormal symptom occurrence. Response options classified as abnormal are shown in boldface type. All 
studies used the same response options for both SUI and UUI.  
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Certainty Assessment  Summary of findings 
№ of 
participa
nts 
(studies) 
Risk 
of 
bias 
Inconsiste
ncy 
Indirectn
ess 
Imprecisi
on 
Publicati
on bias 
Large 
magnitu
de of 
effect 
Dose-
respons
e 
gradien
t 
Plausible 
confound
ers or 
biases 
Overall 
certaint
y of 
evidenc
e 
Effect 
estim
ate 
(95% 
CI) 
Anticipated 
effects after 
surgery 
Any UI improvement or resolution  
2,772 
(30 
studies) 
seriou
s1 
serious2 not 
serious3 
not 
serious4 
none5 yes6 N/A no6 ⨁◯◯
◯ 
VERY 
LOW 
56%  
(48-
63%) 
Any UI was 
improved or 
resolved in 
56% patients   
Stress UI improvement or resolution  
1,186 
(13 
studies) 
seriou
s1 
serious2 not 
serious3 
not 
serious4 
none5 yes6 N/A no6 ⨁◯◯
◯ 
VERY 
LOW 
51%  
(40-
63%) 
Stress UI was 
improved or 
resolved in 
51% patients   
Urge UI improvement or resolution  
720 
(8 
studies) 
seriou
s1 
serious2 not 
serious3 
not 
serious4 
none5 yes6 N/A no6 ⨁◯◯
◯ 
VERY 
LOW 
53%  
(32-
73%) 
Urge UI was 
improved or 
resolved in 
53% patients   
Worsening or new onset of UI  
1,302 
(8 
studies) 
seriou
s1 
serious2 not 
serious3 
not 
serious4 
none5 yes6 N/A no6 ⨁◯◯
◯ 
VERY 
LOW 
3%  
(0-
13%) 
There was 
new onset or 
worsening of 
UI in 3% 
patients   
Urogenital Distress Inventory (UDI) 
473 
(6 
studies) 
seriou
s1 
serious2 not 
serious3 
not 
serious4 
none5 no6 N/A no6 ⨁◯◯
◯ 
VERY 
LOW 
MD 
13.41  
(7.23-
19.59)  
Improvement 
of UDI was 
13.41 
International Consultation on Incontinence Questionnaire (ICIQ) 
568 
(7 
studies) 
seriou
s1 
serious2 not 
serious3 
not 
serious4 
none5 no6 N/A no6 ⨁◯◯
◯ 
VERY 
LOW 
MD 4  
(2.32-
5.69)  
Improvement 
of ICIQ was 
4.00 
Incontinence Impact Questionnaire (IIQ) 
513 
(7 
studies) 
seriou
s1 
not 
serious2 
not 
serious3 
not 
serious4 
none5 no6 N/A no6 ⨁◯◯
◯ 
VERY 
LOW 
MD 
5.28  
(3.92-
6.64)  
Improvement 
of IIQ was 
5.28 
Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ) 
283 
(5 
studies) 
seriou
s1 
serious2 not 
serious3 
serious4 none5 no6 N/A no6 ⨁◯◯
◯ 
VERY 
LOW 
MD -
0.29  
(-2.39-
1.80)  
There was no 
significant 
difference in 
PISQ scores  
Table 3. Grading of Recommendations, Assessment, Development and Evaluation (GRADE) 
certainty of evidence summary table for meta-analyzed outcomes (MD, mean difference, CI, 
confidence interval, UI, urinary incontinence) 
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